Diasome Pharmaceuticals, Inc. — Form D

Diasome Pharmaceuticals, Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-15. The offering totals $15.6M, of which $3.1M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Robert GehoDirectorCleveland, OH
W. Blair GehoDirectorCleveland, OH
Frank Blair McCaneyDirectorCleveland, OH
Thomas Blair McDonaldDirectorCleveland, OH
Cosme Blair OrdonezDirectorCleveland, OH
Peter Blair TollmanDirectorCleveland, OH
Robert GehoExecutive OfficerCleveland, OH
W. Blair GehoExecutive OfficerCleveland, OH
Devang KantesariaDirectorMiami, FL
Marc PennDirectorCleveland, OH
Robert GehoPromoterCleveland, OH
Thomas McDonaldDirectorMiami, FL
Marc Blair PennDirectorCleveland, OH
Frank McCaneyDirectorPhiladelphia, PA
W. Blair GehoDirectorCleveland, OH
Michele Blair OllierDirectorCleveland, OH
Helga Blair KautskyExecutive OfficerCleveland, OH
Guiseppe Blair ZoccoDirectorCleveland, OH
Richard Blair CarusoDirectorCleveland, OH
Len RosenbergDirectorConshohocken, PA
Len RosenbergExecutive OfficerConshohocken, PA
Richard CarusoDirectorVillanova, PA
Brenda GavinDirectorPhiladelphia, PA

Other filings by this issuer (7)

FiledFormOfferingSold
2023-06-30D$15.0M$9.0M
2022-09-08D$19.1M$16.7M
2020-12-23D$5.0M$1.5M
2020-04-01D$2.9M$2.9M
2018-10-26D$18.6M$12.1M
2017-01-17D$8.0M$4.3M
2009-04-13D/A$13.4M$12.9M

More